Additionally, plasma membrane expression of the metalloprotease ADAM17 by M-MDSCs has been proposed to downregulate L-selectin in T cells, thereby impairing their extravasation from the lymphatic system and migration into tumor lesions [199]. This evidence concerns the gene SELL and neoplasm.